PRESS RELEASE published on 02/07/2024 at 07:45, 1 year 2 months ago Marinomed Biotech AG with important progress for Carragelose in 2024 Marinomed Biotech AG enrolls first patient in clinical study for Carragelose eye drops and receives patents in Singapore, South Korea, and Brazil, strengthening its IP portfolio. The company plans to launch Carragelose eye drops and nasal spray in 2024, targeting allergy and eye care markets Clinical Study Marinomed Biotech AG Carragelose Patents Allergy And Eye Care Markets
PRESS RELEASE published on 10/17/2023 at 07:45, 1 year 6 months ago Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume
PRESS RELEASE published on 08/17/2023 at 07:45, 1 year 8 months ago Marinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities
PRESS RELEASE published on 08/09/2023 at 07:45, 1 year 8 months ago Marinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories Co. Ltd.
PRESS RELEASE published on 07/27/2023 at 07:45, 1 year 9 months ago Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico
PRESS RELEASE published on 07/13/2023 at 07:45, 1 year 9 months ago Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan
PRESS RELEASE published on 06/21/2023 at 17:00, 1 year 10 months ago Marinomed Biotech AG: Annual General Meeting elects Dr. Eva Hofstädter-Thalmann as a new member of the Supervisory Board
PRESS RELEASE published on 06/15/2023 at 07:45, 1 year 10 months ago Marinomed Biotech AG prepares launch of Carragelose eye drops in 2024
PRESS RELEASE published on 05/23/2023 at 07:45, 1 year 11 months ago Marinomed Biotech AG reports best first quarter in company history
PRESS RELEASE published on 04/19/2023 at 07:45, 2 years ago Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023
Published on 05/03/2025 at 03:40, 1 day 22 hours ago Snipp Interactive Announces Delay in Filing Audited Fiscal 2024 Financial Statements
Published on 05/03/2025 at 03:00, 1 day 23 hours ago Vision Marine Technologies Inc. Announces Postponement of Annual Meeting of Shareholders
Published on 05/03/2025 at 02:06, 2 days ago Battery X Metals Achieves Pivotal Milestone with Delivery of Next-Generation Lithium-Ion Battery Rebalancing Machine and Announces Exclusive Live Reveal Event
Published on 05/02/2025 at 23:30, 2 days 2 hours ago RE Royalties Announces Fiscal 2024 Year End Results and Highlights
Published on 05/02/2025 at 15:00, 2 days 11 hours ago Newsmax #1 in Cable News for Key Demo Ratings Growth
Published on 05/03/2025 at 07:57, 1 day 18 hours ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31,2024
Published on 05/02/2025 at 19:00, 2 days 7 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 05/02/2025 at 18:41, 2 days 7 hours ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 05/04/2025 at 22:39, 3 hours 40 minutes ago Déclaration des transactions sur actions propres réalisées du 22 au 25 avril 2025
Published on 05/04/2025 at 22:39, 3 hours 40 minutes ago Disclosure of trading in own shares between April 22nd and April 25th, 2025
Published on 05/02/2025 at 17:35, 2 days 8 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
